ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Adorx Therapeutics Limited

Adorx Therapeutics Limited is an active company incorporated on 24 February 2017 with the registered office located in Edinburgh, City of Edinburgh. Adorx Therapeutics Limited was registered 8 years ago.
Status
Active
Active since incorporation
Company No
SC558719
Private limited company
Scottish Company
Age
8 years
Incorporated 24 February 2017
Size
Unreported
Confirmation
Submitted
Dated 24 February 2025 (8 months ago)
Next confirmation dated 24 February 2026
Due by 10 March 2026 (4 months remaining)
Last change occurred 8 months ago
Accounts
Due Soon
For period 1 Mar28 Feb 2024 (12 months)
Accounts type is Full
Next accounts for period 28 February 2025
Due by 30 November 2025 (22 days remaining)
Address
137a George Street
Edinburgh
EH2 4JY
Same address for the past 7 years
Telephone
0131 2433704
Email
Unreported
Website
People
Officers
3
Shareholders
11
Controllers (PSC)
2
Director • British • Lives in UK • Born in Feb 1962
Director • British • Lives in England • Born in Jul 1967
Director • American • Lives in United States • Born in Jun 1965
Epidarex Capital Partners Limited
PSC
CRT Pioneer GP Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Bioindustry Association
Dr Peter Michael Finan is a mutual person.
Active
Theraview Consulting Ltd
Dr Peter Michael Finan is a mutual person.
Active
Leucid Bio Ltd
Dr Peter Michael Finan is a mutual person.
Active
Epsilogen Ltd
Dr Peter Michael Finan is a mutual person.
Active
Theolytics Ltd
Dr Peter Michael Finan is a mutual person.
Active
Lunac Therapeutics Limited
Dr Peter Michael Finan is a mutual person.
Active
Curve Therapeutics Limited
Dr Peter Michael Finan is a mutual person.
Active
Enterprise Therapeutics Holdings Limited
Dr Peter Michael Finan is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2018–2024)
Period Ended
28 Feb 2024
For period 28 Feb28 Feb 2024
Traded for 12 months
Cash in Bank
£5.44M
Decreased by £7.05M (-56%)
Turnover
£12.8M
Decreased by £1.23M (-9%)
Employees
3
Same as previous period
Total Assets
£9.22M
Decreased by £3.39M (-27%)
Total Liabilities
-£1.37M
Decreased by £533K (-28%)
Net Assets
£7.85M
Decreased by £2.85M (-27%)
Debt Ratio (%)
15%
Decreased by 0.25% (-2%)
Latest Activity
Confirmation Submitted
8 Months Ago on 24 Feb 2025
Full Accounts Submitted
1 Year 1 Month Ago on 24 Sep 2024
Confirmation Submitted
1 Year 7 Months Ago on 20 Mar 2024
Small Accounts Submitted
1 Year 11 Months Ago on 30 Nov 2023
Confirmation Submitted
2 Years 8 Months Ago on 13 Mar 2023
Elizabeth Ann Roper Resigned
2 Years 8 Months Ago on 21 Feb 2023
Crt Pioneer Gp Limited (PSC) Appointed
7 Years Ago on 9 Mar 2018
Epidarex Capital Partners Limited (PSC) Details Changed
8 Years Ago on 27 Jun 2017
Epidarex Capital Partners Limited (PSC) Details Changed
8 Years Ago on 26 Jun 2017
Epidarex Capital Partners Limited (PSC) Details Changed
8 Years Ago on 26 Jun 2017
Get Credit Report
Discover Adorx Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 24 February 2025 with updates
Submitted on 24 Feb 2025
Full accounts made up to 28 February 2024
Submitted on 24 Sep 2024
Confirmation statement made on 24 February 2024 with updates
Submitted on 20 Mar 2024
Resolutions
Submitted on 20 Dec 2023
Memorandum and Articles of Association
Submitted on 20 Dec 2023
Accounts for a small company made up to 28 February 2023
Submitted on 30 Nov 2023
Notification of Crt Pioneer Gp Limited as a person with significant control on 9 March 2018
Submitted on 22 Mar 2023
Change of details for Epidarex Capital Partners Limited as a person with significant control on 27 June 2017
Submitted on 21 Mar 2023
Solvency Statement dated 20/03/23
Submitted on 21 Mar 2023
Statement of capital on 21 March 2023
Submitted on 21 Mar 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year